PROBLEMS WITH THE EQUIVALENCE CONCEPT IN THE THERAPEUTIC USE OF GLUCOCORTICOIDS - COMPARISON OF CLINICAL PHARMACOKINETICS AND PHARMACODYNAMICS OF PREDNISOLONE AND METHYLPREDNISOLONE

被引：6

作者：

BARTH, J ^{[1
]}

MOLLMANN, HW ^{[1
]}

WAGNER, T ^{[1
]}

HOCHHAUS, G ^{[1
]}

DERENDORF, H ^{[1
]}

机构：

[1] UNIV FLORIDA,COLL PHARM,GAINESVILLE,FL 32610

来源：

DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT | 1994年 / 119卷 / 48期

关键词：

D O I：

10.1055/s-2008-1058886

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：1671 / 1676

页数：6

共 38 条

[1]

ANGELI A, 1978, CLIN PHARMACOL THER, V23, P47

[2] DISPOSITION OF PULSE DOSE METHYLPREDNISOLONE IN ADULT AND PEDIATRIC-PATIENTS WITH THE NEPHROTIC SYNDROME [J].

ASSAEL, BM ;

BANFI, G ;

APPIANI, AC ;

EDEFONTI, A ;

JUSKO, WJ .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 23 (05) :429-433

[3] DIFFERENCES IN CEREBROSPINAL-FLUID PENETRATION OF CORTICOSTEROIDS - POSSIBLE RELATIONSHIP TO THE PREVENTION OF MENINGEAL LEUKEMIA [J].

BALIS, FM ;

LESTER, CM ;

CHROUSOS, GP ;

HEIDEMAN, RL ;

POPLACK, DG .

JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (02) :202-207

[4] INTERLEUKIN-6 INHIBITS CORTICOSTEROID-BINDING GLOBULIN SYNTHESIS BY HUMAN HEPATOBLASTOMA-DERIVED (HEP G2) CELLS [J].

BARTALENA, L ;

HAMMOND, GL ;

FARSETTI, A ;

FLINK, IL ;

ROBBINS, J .

ENDOCRINOLOGY, 1993, 133 (01) :291-296

[5]

BARTH J, 1987, ATEMWEG LUNGENKRANK, V13, P324

[6]

BARTH J, 1984, ATEMWEG LUNGENKRANK, V10, P410

[7]

BARTH J, 1992, INT J CLIN PHARM TH, V30, P317

[8]

BARTH J, 1992, INTENS CARE MED S2, V18, pS160

[9]

BRAUDE AC, 1983, LANCET, V2, P995

[10] KINETICS OF METHYLPREDNISOLONE AND ITS HEMISUCCINATE ESTER [J].

DERENDORF, H ;

MOLLMANN, H ;

ROHDEWALD, P ;

REHDER, J ;

SCHMIDT, EW .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1985, 37 (05) :502-507

← 1 2 3 4 →